Trial Profile
Evaluation of the Clinical Efficacy of Leukine Administered in Conjunction With Paclitaxel in Patients With Advanced Melanoma
Status:
Suspended
Phase of Trial:
Phase II
Latest Information Update: 10 Nov 2021
Price :
$35
*
At a glance
- Drugs Sargramostim (Primary) ; Paclitaxel
- Indications Malignant melanoma
- Focus Therapeutic Use
- 10 Nov 2006 New trial record.